Bank of New York Mellon Corp - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 194 filers reported holding ACORDA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$17,000
+30.8%
25,2000.0%0.00%
Q3 2020$13,000
-31.6%
25,2000.0%0.00%
Q2 2020$19,000
-96.2%
25,200
-95.2%
0.00%
Q1 2020$494,000
-55.3%
529,271
-2.2%
0.00%
Q4 2019$1,104,000
-20.2%
541,307
+12.2%
0.00%
Q3 2019$1,384,000
-62.6%
482,305
+0.0%
0.00%
-100.0%
Q2 2019$3,698,000
-65.1%
482,170
-39.6%
0.00%
-66.7%
Q1 2019$10,605,000
+41.1%
797,932
+65.4%
0.00%
+50.0%
Q4 2018$7,515,000
-23.5%
482,346
-3.5%
0.00%
-33.3%
Q3 2018$9,821,000
-35.2%
499,811
-5.4%
0.00%
-25.0%
Q2 2018$15,167,000
+17.7%
528,443
-3.1%
0.00%0.0%
Q1 2018$12,891,000
+5.4%
545,113
-4.4%
0.00%
+33.3%
Q4 2017$12,232,000
-7.0%
570,270
+2.5%
0.00%
-25.0%
Q3 2017$13,155,000
+22.8%
556,239
+2.3%
0.00%
+33.3%
Q2 2017$10,712,000
-12.4%
543,759
-6.6%
0.00%0.0%
Q1 2017$12,229,000
+18.4%
582,298
+6.0%
0.00%0.0%
Q4 2016$10,328,000
-5.7%
549,320
+4.8%
0.00%0.0%
Q3 2016$10,947,000
-18.4%
524,278
-0.3%
0.00%
-25.0%
Q2 2016$13,408,000
-7.0%
525,692
-3.5%
0.00%0.0%
Q1 2016$14,412,000
-51.9%
544,850
-22.2%
0.00%
-55.6%
Q4 2015$29,950,000
+61.1%
700,086
-0.2%
0.01%
+50.0%
Q3 2015$18,589,000
-15.2%
701,243
+6.6%
0.01%0.0%
Q2 2015$21,916,000
+3.9%
657,583
+3.7%
0.01%
+20.0%
Q1 2015$21,097,000
+24.0%
633,941
+52.3%
0.01%
+25.0%
Q4 2014$17,011,000
+6.0%
416,233
-12.2%
0.00%0.0%
Q3 2014$16,055,000
-50.9%
473,860
-51.1%
0.00%0.0%
Q2 2014$32,692,000
+69.3%
969,780
+90.4%
0.00%
-20.0%
Q1 2014$19,313,000
+31.2%
509,444
+1.0%
0.01%
+25.0%
Q4 2013$14,722,000
-51.4%
504,199
-43.1%
0.00%
-20.0%
Q3 2013$30,282,000
+122.3%
885,360
+114.4%
0.01%
+25.0%
Q2 2013$13,622,000412,8860.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders